TSXV - Delayed Quote CAD
Evome Medical Technologies Inc. (EVMT.V)
0.0100
+0.0050
+(100.00%)
At close: 1:43:52 PM EDT
Breakdown
TTM
12/31/2023
2/28/2022
2/28/2021
Total Revenue
48,342.2030
62,627.4510
18,312.2690
18,312.2690
Cost of Revenue
32,000.5630
40,094.4470
12,350.2020
12,350.2020
Gross Profit
16,341.6400
22,533.0040
5,962.0670
5,962.0670
Operating Expense
21,838.8360
28,664.7990
6,570.0130
10,412.7470
Operating Income
-5,497.1960
-6,131.7950
-607.9460
-4,450.6800
Net Non Operating Interest Income Expense
-2,981.1060
-2,639.9900
-388.0650
-388.0650
Other Income Expense
-15,033.0320
-6,774.0610
-3,477.6250
365.1090
Pretax Income
-23,511.3330
-15,545.8460
-4,473.6360
-4,473.6360
Tax Provision
20.7990
57.0690
-101.6170
-101.6170
Net Income Common Stockholders
-23,532.1320
-15,602.9150
-4,372.0190
-4,372.0190
Diluted NI Available to Com Stockholders
-23,532.1320
-15,602.9150
-4,372.0190
-4,372.0190
Basic EPS
-0.29
-0.21
-0.10
-0.10
Diluted EPS
-0.29
-0.21
-0.10
-0.10
Basic Average Shares
88,216.7540
73,471.6960
43,627.0510
43,627.0510
Diluted Average Shares
88,216.7540
73,471.6960
43,627.0510
43,627.0510
Total Operating Income as Reported
--
-5,521.9490
--
-607.9460
Total Expenses
53,839.3990
68,759.2460
18,920.2150
22,762.9490
Net Income from Continuing & Discontinued Operation
-23,532.1320
-15,602.9150
-4,372.0190
-4,372.0190
Normalized Income
-11,666.8660
-8,681.8238
-4,728.8347
-4,728.8347
Interest Expense
2,981.1060
2,639.9900
388.0650
388.0650
Net Interest Income
-2,981.1060
-2,639.9900
-388.0650
-388.0650
EBIT
-20,530.2270
-12,905.8560
-4,085.5710
-4,085.5710
EBITDA
-16,638.7510
-8,396.9290
-3,243.8050
-3,243.8050
Reconciled Cost of Revenue
34,024.5190
42,118.4030
12,350.2020
12,350.2020
Reconciled Depreciation
1,867.5200
2,484.9710
841.7660
841.7660
Net Income from Continuing Operation Net Minority Interest
-23,532.1320
-15,602.9150
-4,372.0190
-4,372.0190
Total Unusual Items Excluding Goodwill
-15,019.3240
-8,760.8750
365.1090
365.1090
Total Unusual Items
-15,019.3240
-8,760.8750
365.1090
365.1090
Normalized EBITDA
-1,619.4270
363.9460
-3,608.9140
-3,608.9140
Tax Rate for Calcs
0.0002
0.0002
0
0
Tax Effect of Unusual Items
-3,154.0580
-1,839.7838
8.2933
8.2933
2/28/2021 - 3/31/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade